United Kingdom has begun large-scale trial of new treatment that will help stop COVID-19 patients from developing severe illness.

United Kingdom has begun large-scale trial of new treatment that will help stop COVID-19 patients from developing severe illness.

The treatment involves inhaling a protein called interferon beta which the body produces when it gets a viral infection.

The trial it is hoped will stimulate the immune system, priming cells to be ready to fight off viruses.

The drug is a special formulation of interferon beta delivered directly to the airways via a nebulizer which makes the protein into an aerosol.



Comments are Closed